Publication

Byline

EC Meet of Rehab Council: CS clears Rs 12.95 cr initiatives

SRINAGAR, Sept. 21 -- Chief Secretary, Atal Dulloo today chaired the 12th Executive Council Meeting of the J&K Rehabilitation Council for Orphans, Women and Disabled Persons to review its functioning,... और पढ़ें


King Jaja's challenge to Nigeria: Power, defiance and economic self-determination, By Dakuku Peterside

Nigeria, Sept. 21 -- If King Jaja of Opobo were alive in Nigeria today, where would he stand in a country wrestling with diplomatic pressures, economic uncertainty and deepening social tensions - and ... और पढ़ें


YSRCP demands CBI probe into DSC scam, calls for Minister Lokesh's resignation

New Delhi, Sept. 21 -- The controversy over the District Selection Committee (DSC) recruitment scam is intensifying in Andhra Pradesh. Yuvajana Sramika Rythu Congress Party (YSRCP) spokesperson Konda ... और पढ़ें


Bank Strike Sept 28-30: What consumers should know about UPI, ATM transaction, cash withdrawal from SBI, HDFC Banks

New Delhi, Sept. 21 -- Bank employees and officials across India are going for a three-day strike From 28 September in order to demand a five-day work week in line with the central bank, the Reserve B... और पढ़ें


Large-cap funds in the red: 29 of 33 schemes deliver negative returns in 1 year, category average at -3.09%

New Delhi, Sept. 21 -- Active large-cap mutual funds have had a difficult year. The category average return stands at -3.09% over the past one year, with only four of the 33 funds in the category deli... और पढ़ें


Old Settlements in No Development Areas to Be Removed from Restrictions: Rane

Goa, Sept. 21 -- Town and Country Planning (TCP) Minister Vishwajit Rane has said that old settlements and settlement pockets currently mapped under No Development Areas (NDA) and No Development Zones... और पढ़ें


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... और पढ़ें


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... और पढ़ें


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pl... और पढ़ें


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solu... और पढ़ें